As of January 1, 2026, Ulan Sarymsakov, a clinical specialist from the Republican Center for the Control of Hemocontact Viral Hepatitis and HIV, presented new data on the epidemiological situation regarding viral hepatitis in Kyrgyzstan.
According to his information, monitoring began in 2022. During the studies, 1,140,946 people were tested for hepatitis B virus, of which 37,946 (3.33%) tested positive. For hepatitis C virus, 1,137,130 people were examined, with positive results found in 11,035 (0.97%).
Additionally, from 2024 to 2025, 26,925 people were tested for hepatitis D virus, of which 919 (3.4%) had positive results.
Currently, 19,325 people are registered with hepatitis B, of which 5,439 are undergoing treatment. There are 3,363 patients registered with hepatitis D, 2,674 of whom are receiving therapy. Regarding hepatitis C, 10,862 people are registered, with 6,890 receiving necessary treatment.
Ulan Sarymsakov also reported on the progress of vaccination against hepatitis B: the first dose was received by 312,447 people, the second dose by 256,144 (which is 82% of those who received the first dose), and the third dose by 191,883 (75% of those who received the second dose).
